Skip to main content
logo
Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
10.09
-0.47 (-4.45%)
Oct 30, 2026, 11:45 AM EDT - Market open

Kura Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
8989046771,068847932
Market Cap Growth
-1.60%33.48%-36.58%26.07%-9.08%-56.80%
Enterprise Value
403374239633425396
Last Close Price
10.5610.398.7114.3812.4114.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
12.1613.4012.57---
PB Ratio
19.405.191.642.692.021.84
P/TBV Ratio
19.405.191.642.692.021.84
P/FCF Ratio
--5.06---
P/OCF Ratio
--5.04---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.765.544.43---
EV/FCF Ratio
--1.78---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.510.120.040.040.030.01
Debt / FCF Ratio
--0.12---
Net Debt / Equity Ratio
-10.21-3.71-1.72-1.02-1.01-1.01
Net Debt / EBITDA Ratio
1.562.143.702.473.053.91
Net Debt / FCF Ratio
4.219.15-5.313.253.834.84
Asset Turnover
0.120.090.09---
Quick Ratio
4.505.819.3112.0518.2423.13
Current Ratio
4.736.069.4612.2618.5623.26
Return on Equity (ROE)
-167.71%-94.82%-42.91%-37.34%-29.31%-23.35%
Return on Assets (ROA)
-31.30%-25.33%-19.97%-22.89%-17.65%-13.89%
Return on Capital Employed (ROCE)
-67.70%-48.90%-28.40%-40.10%-32.40%-25.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-33.31%-30.82%-25.69%-14.29%-16.04%-14.00%
FCF Yield
-12.50%-7.82%19.76%-11.70%-13.07%-11.34%
Buyback Yield / Dilution
-1.16%-1.76%-17.66%-9.31%-0.96%-25.01%
SEC Filings: 10-K · 10-Q